176 related articles for article (PubMed ID: 30478008)
1. Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study.
Breier A; Buchanan RW; D'Souza D; Nuechterlein K; Marder S; Dunn W; Preskorn S; Macaluso M; Wurfel B; Maguire G; Kakar R; Highum D; Hoffmeyer D; Coskinas E; Litman R; Vohs JL; Radnovich A; Francis MM; Metzler E; Visco A; Mehdiyoun N; Yang Z; Zhang Y; Yolken RH; Dickerson FB
Schizophr Res; 2019 Apr; 206():291-299. PubMed ID: 30478008
[TBL] [Abstract][Full Text] [Related]
2. Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial.
Prasad KM; Eack SM; Keshavan MS; Yolken RH; Iyengar S; Nimgaonkar VL
Schizophr Bull; 2013 Jul; 39(4):857-66. PubMed ID: 22446565
[TBL] [Abstract][Full Text] [Related]
3. Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial.
Devanand DP; Andrews H; Kreisl WC; Razlighi Q; Gershon A; Stern Y; Mintz A; Wisniewski T; Acosta E; Pollina J; Katsikoumbas M; Bell KL; Pelton GH; Deliyannides D; Prasad KM; Huey ED
BMJ Open; 2020 Feb; 10(2):e032112. PubMed ID: 32034019
[TBL] [Abstract][Full Text] [Related]
4. Emotion discrimination in humans: Its association with HSV-1 infection and its improvement with antiviral treatment.
Bhatia T; Wood J; Iyengar S; Narayanan SS; Beniwal RP; Prasad KM; Chen K; Yolken RH; Dickerson F; Gur RC; Gur RE; Deshpande SN; Nimgaonkar VL
Schizophr Res; 2018 Mar; 193():161-167. PubMed ID: 28830742
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
6. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
7. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
8. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
Handsfield HH; Warren T; Werner M; Phillips JA
Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
[TBL] [Abstract][Full Text] [Related]
9. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
[TBL] [Abstract][Full Text] [Related]
11. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
[TBL] [Abstract][Full Text] [Related]
12. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial.
Aurelius E; Franzen-Röhl E; Glimåker M; Akre O; Grillner L; Jorup-Rönström C; Studahl M;
Clin Infect Dis; 2012 May; 54(9):1304-13. PubMed ID: 22460966
[TBL] [Abstract][Full Text] [Related]
13. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample.
Yolken RH; Torrey EF; Lieberman JA; Yang S; Dickerson FB
Schizophr Res; 2011 May; 128(1-3):61-5. PubMed ID: 21353483
[TBL] [Abstract][Full Text] [Related]
14. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
15. Valacyclovir to expedite the clearance of recurrent herpes gladiatorum.
Anderson BJ
Clin J Sport Med; 2005 Sep; 15(5):364-6. PubMed ID: 16162997
[TBL] [Abstract][Full Text] [Related]
16. A pilot study examining the safety and tolerability of valacyclovir in veterans with hepatitis C virus/herpes simplex virus type 2 coinfection.
Burton MJ; Penman A; Sunesara I; McGuire BM; Hook EW
Am J Med Sci; 2014 Dec; 348(6):455-9. PubMed ID: 25163019
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of valacyclovir in preventing reactivation of herpes gladiatorum in wrestlers.
Anderson BJ
Clin J Sport Med; 1999 Apr; 9(2):86-90. PubMed ID: 10442623
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
19. Persistent infection by HSV-1 is associated with changes in functional architecture of iPSC-derived neurons and brain activation patterns underlying working memory performance.
D'Aiuto L; Prasad KM; Upton CH; Viggiano L; Milosevic J; Raimondi G; McClain L; Chowdari K; Tischfield J; Sheldon M; Moore JC; Yolken RH; Kinchington PR; Nimgaonkar VL
Schizophr Bull; 2015 Jan; 41(1):123-32. PubMed ID: 24622295
[TBL] [Abstract][Full Text] [Related]
20. The impact of Herpes simplex virus type 1 on cognitive impairments in young, healthy individuals - A historical prospective study.
Fruchter E; Goldberg S; Fenchel D; Grotto I; Ginat K; Weiser M
Schizophr Res; 2015 Oct; 168(1-2):292-6. PubMed ID: 26362735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
